Decade-long trends in the characteristics, management and hospital outcomes of diabetic patients with ST-segment elevation myocardial infarction

Diabetes and Vascular Disease Research

Volumn 11, Issue 3, 2014, Pages 182-189

  Tisminetzky, Mayra ^a   Joffe, Samuel ^a   McManus, David D ^a   Darling, Chad ^a   Gore, Joel M ^a   Yarzebski, Jorge ^a   Lessard, Darleen ^a   Goldberg, Robert J ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Diabetes; hospital prognosis; ST segment elevation myocardial infarction

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BODY MASS; CARDIOGENIC SHOCK; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART FAILURE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNITED STATES; AGE; CASE CONTROL STUDY; COHORT ANALYSIS; DIABETES COMPLICATIONS; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TRENDS;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; BODY MASS INDEX; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY ARTERY BYPASS; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84900329836     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164114524235     Document Type: Article

References (29)

1. Heart and stroke 2012 statistical update. Dallas, TX: American Heart Association ; 2012 :
2. Berger A, Breall J, Gersh B, et al. Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project). Am J Cardiol. 2001 ; 87: 272-277
3. Crowley A, Menon V, Lessard D, et al. Sex differences in survival after acute myocardial infarction in patients with diabetes mellitus (Worcester Heart Attack Study). Am Heart J. 2003 ; 146: 824-831
4. Murcia A, Hennekens C, Lamas G, et al. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Arch Intern Med. 2004 ; 164: 2273-2279
5. Abbud ZA, Shindler DM, Wilson AC, et al. Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Myocardial Infarction Data Acquisition System Study Group. Am Heart J. 1995 ; 130: 51-58
6. Eagle K, Nallamothu B, Mehta R, et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J. 2008 ; 29: 609-617
7. Kushner FG, Hand M, Smith SC, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009 ; 54: 2205-2241
8. Kralev S, Krause B, Papavassiliu T, et al. Clinical outcome of patients with diabetes presenting with ST-elevation myocardial infarction and treated with concomitant use of glycoprotein IIb/IIIa inhibitors. Cardiol J. 2009 ; 16: 234-240
9. Zairis MN, Lyras AG, Makrygiannis SS, et al. Type 2 diabetes and intravenous thrombolysis outcome in the setting of ST elevation myocardial infarction. Diabetes Care. 2004 ; 27: 967-971
10. Van der Schaaf RJ, Henriques JP, Wiersma JJ, et al. Primary percutaneous coronary intervention for patients with acute ST elevation myocardial infarction with and without diabetes mellitus. Heart. 2006 ; 92: 117-118
11. Floyd KC, Yarzebski J, Spencer FA, et al. A 30 year perspective (1975-2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study. Circ Cardiovasc Qual Outcomes. 2009 ; 2: 88-95
12. Goldberg RJ, Spencer FA, Yarzebski J, et al. A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study). Am J Cardiol. 2004 ; 94: 1373-1378
13. Goldberg RJ, Gore JM, Alpert JS, et al. Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study. JAMA. 1986 ; 255: 2774-2779
14. Goldberg R, Kramer D, Lessard D, et al. Serum glucose levels and hospital outcomes in patients with acute myocardial infarction without prior diabetes: a community-wide perspective. Coron Artery Dis. 2007 ; 18: 125-131
15. Goldberg RJ, Yarzebski J, Lessard D, et al. Decade-long trends and factors associated with time to hospital presentation in patients with acute myocardial infarction: the Worcester Heart Attack Study. Arch Intern Med. 2000 ; 160: 3217-3223
16. Saczynski JS, McManus D, Zhou Z, et al. Trends in atrial fibrillation complicating acute myocardial infarction. Am J Cardiol. 2009 ; 104: 169-174
17. Goldberg RJ, Spencer FA, Gore JM, et al. Thirty year trends (1975-2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009 ; 119: 1211-1219
18. Saczynski JS, Spencer FA, Gore JM, et al. Twenty-year trends in the incidence rates of stroke complicating acute myocardial infarction: the Worcester Heart Attack Study. Arch Intern Med. 2008 ; 168: 2104-2110
19. McManus DD, Chinali M, Saczynski JS, et al. Thirty-year trends in heart failure in patients hospitalized with acute myocardial infarction. Am J Cardiol. 2011 ; 107: 353-359
20. Kahn M, Cubbon R, Mercer B, et al. Association of diabetes with increased all-cause mortality following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the contemporary era. Diab Vasc Dis Res. 2012 ; 9: 3-9
21. Brener S, Mehran R, Dressler O, et al. Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI). Am J Cardiol. 2012 ; 109: 1111-1116
22. AuliA V, EteroviA D, MiriA D, et al. Symptom presentation of acute myocardial infarction: influence of sex, age, and risk factors. Am Heart J. 2002 ; 144: 1012-1017
23. Gore MO, Patel MJ, Kosiborod M, et al. National Registry of Myocardial Infarction Investigators. Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the National Registry of Myocardial Infarction. Circ Cardiovasc Qual Outcomes. 2012 ; 5: 791-797
24. Eagle KA, Goodman SG, Avezum Á, et al. GRACE Investigators. Practice variation and missed opportunities for reperfusion in ST-segment elevation myocardial infarction findings from the Global Registry of Acute Coronary Events (GRACE). Lancet. 2002 ; 359: 373-377
25. Gharacholou SM, Alexander KP, Chen AY, et al. Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRUSADE initiative. Am Heart J. 2010 ; 159: 757-763
26. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol. 2000 ; 36: 970-1062
27. Iribarren C, Karter AJ, Go AS, et al. Glycemic control and heart failure among adult patients with diabetes. Circulation. 2001 ; 103: 2668-2673
28. Timmer J, Ottervanger J, Thomas K, et al. Long-term, cause-specific mortality after myocardial infarction in diabetes. Eur Heart J. 2004 ; 25: 926-931
29. Lindholm M, Boesgaard S, Torp-Pedersen C. Diabetes mellitus and cardiogenic shock in acute myocardial infarction. Eur J Heart Fail. 2005 ; 7: 834-839